Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Mebeverine hydrochloride | C25H35NO5.ClH | 2753-45-9 | Details |
| BF 227 | C16H16FN3O2S | 845647-80-5 | Details |
| BGB-102；JNJ-26483327 | C22H25BrN4O2 | 807640-87-5 | Details |
| ODM-207 | C22H21N3O3 | 1801503-93-4 | Details |
| BI-1408 | C22H23FN6 | 2231075-94-6 | Details |
| Proglumide | C18H26N2O4 | 6620-60-6 | Details |
| β3-AR agonist 1 | C22H28N4O4S | 1283125-73-4 | Details |
| I-BET282；BET-IN-1 | C25H30N4O4 | 1422554-34-4 | Details |
| BET-IN-2 | C23H29N3O | 2104688-91-5 | Details |
| β-Cryptoxanthin；(3R)-β-Cryptoxanthin | C40H56O | 472-70-8 | Details |
| β-NF-JQ1 | C45H42ClN5O6S | 2380000-55-3 | Details |
| Betrixaban-d6；Betrixaban D6 | C23H22ClN5O3 | 2098655-51-5 | Details |
| BF-168 | C18H17FN2O2 | 634911-47-0 | Details |
| Bexarotene D4；LGD1069 D4 | C24H24D4O2 | 2182068-00-2 | Details |
| BI 653048 | C23H25F4N3O4S | 1198784-72-3 | Details |
| BI 653048 phosphate | C23H28F4N3O8PS | 1198784-97-2 | Details |
| BI-9321 | C22H21FN4 | 2387510-86-1 | Details |
| BI-9321 trihydrochloride | C22H22ClFN4 | 2387510-87-2 | Details |
| BI-2852 | C31H28N6O2 | 2375482-51-0 | Details |
| Tolbutamide | C12H18N2O3S | 64-77-7 | Details |
| BI-749327 | C23H21F3N4O2 | 2361241-23-6 | Details |
| BIBO3304 TFA | C31H36F3N7O5 | 191868-14-1 | Details |
| BIIL-260 hydrochloride | C30H31ClN2O3 | 192581-24-1 | Details |
| Bifeprunox | C24H23N3O2 | 350992-10-8 | Details |
| Bicyclomycin benzoate；FR2054 | C19H22N2O8 | 37134-40-0 | Details |
| BRD 4354 | C21H23ClN4O | 315698-07-8 | Details |
| BRD-K98645985 | C33H43N5O4 | 1357647-78-9 | Details |
| BRD-IN-3 | C21H25N5O3 | 2351938-32-2 | Details |
| BRD-6929 | C19H17N3O2S | 849234-64-6 | Details |
| BO-264 | C18H19N5O3 | 2408648-20-2 | Details |
| BRM/BRG1 ATP Inhibitor-1 | C11H9F3N4O2S | 2270879-17-7 | Details |
| Brofaromine；CGP 11305A | C14H16BrNO2 | 63638-91-5 | Details |
| BRL44385 | C8H11N5O3 | 114778-60-8 | Details |
| BRL-42715 | C10H9N4NaO3S | 102209-75-6 | Details |
| BRL 37344 sodium；BRL 37344A | C19H23ClNNaO4 | 127299-93-8 | Details |
| BQ-788 | C34H51N5O7 | 173326-37-9 | Details |
| BPO-27 racemate | C26H18BrN3O6 | 1314873-02-3 | Details |
| Flumequine | C14H12FNO3 | 42835-25-6 | Details |
| BRCA1-IN-2 | C26H33N4O7P | 1622262-55-8 | Details |
| Zatolmilast | C21H15ClF3NO2 | 1606974-33-7 | Details |
| BLM-IN-1 | C28H35FN4O | 2056014-40-3 | Details |
| Isoprenaline hydrochloride | C11H18ClNO3 | 51-30-9 | Details |
| (8R,9S)-Talazoparib；(8R,9S)-BMN-673 | C19H14F2N6O | 1207456-00-5 | Details |
| BM635 | C25H29FN2O | 1493762-74-5 | Details |
| BM-131246 | C22H20N2O4S | 103787-97-9 | Details |
| (4-Acetamidocyclohexyl) nitrate；BM121307 | C8H14N2O4 | 137213-91-3 | Details |
| Bisindolylmaleimide VIII acetate | C24H22N4O2 | 138516-31-1 | Details |
| BIX-01338 hydrate；BIX 01338 hydrate;BIX01338 hydrate | C32H26F3N3O7 | 1228184-65-3 | Details |
| Bixin | C25H30O4 | 6983-79-5 | Details |
| Bitopertin (R enantiomer)；RG1678 (R enantiomer);RO4917838 (R enantiomer);Bitopertin R enantiomer | C21H20F7N3O4S | 845614-12-2 | Details |
| bio-THZ1 | C52H65ClN12O8S | 1604811-14-4 | Details |
| BIO-32546 | C28H31F6NO3 | 1548743-66-3 | Details |
| Biotin-VAD-FMK | C30H49FN6O8S | 1135688-15-1 | Details |
| Bisindolylmaleimide X hydrochloride；Ro31-8425 hydrochloride;BIM-X hydrochloride | C26H25ClN4O2 | 145317-11-9 | Details |
| BIBP3226 TFA | C29H32F3N5O5 | 1068148-47-9 | Details |
| Bithionol sulfoxide | C12H6Cl4O3S | 844-26-8 | Details |
| BPH-1358 | C32H29ClN6O2 | 5352-53-4 | Details |
| Bozitinib | C20H15F3N8 | 1440964-89-5 | Details |
| Carboplatin | C6H12N2O4Pt | 41575-94-4 | Details |
| BO3482 | C14H20N2NaO5S2 * | 198013-53-5 | Details |
| BPN-15606 | C23H23FN6O | 1914989-49-3 | Details |
| BPI-9016M | C25H18F2N4O3 | 1528546-94-2 | Details |
| BPH-652 | C16H16K3O7PS | 157124-84-0 | Details |
| BPH-1358 free base；NSC50460 free base | C32H28N6O2 | 801985-13-7 | Details |
| Borrelidin；Treponemycin | C28H43NO6 | 7184-60-3 | Details |
| BM 957 | C52H56ClF3N6O7S3 | 1391107-54-2 | Details |
| BMY-43748 | C20H17F3N4O3 | 132195-65-4 | Details |
| BMS-470539 dihydrochloride | C32H42ClN5O4 | 2341796-82-3 | Details |
| BMS-654457 | C36H37N5O4 | 1004551-41-0 | Details |
| BMS-1001 hydrochloride | C35H35ClN2O7 | 2113650-04-5 | Details |
| BMS-214662 | C25H23N5O2S2 | 195987-41-8 | Details |
| BMS-191095 | C22H21ClN4O2 | 166095-21-2 | Details |
| BJE6-106；B106 | C26H23NO2 | 1564249-38-2 | Details |
| BKI-1369 | C23H27N7O | 1951431-22-3 | Details |
| Ifosfamide | C7H15Cl2N2O2P | 3778-73-2 | Details |
| BioE-1115 | C19H18FN3O2 | 1268863-35-9 | Details |
| Brevetoxin-3；PbTx-3 | C50H72O14 | 85079-48-7 | Details |
| Brexpiprazole-d8；OPC-34712 D8;Brexpiprazole D8 | C25H27N3O2S | 1427049-21-5 | Details |
| Brexpiprazole S-oxide；DM-3411 | C25H27N3O3S | 1191900-51-2 | Details |
| BRD0705 | C20H23N3O | 2056261-41-5 | Details |
| BRD5648 | C20H23N3O | 2056261-42-6 | Details |
| Toltrazuril | C18H14F3N3O4S | 69004-03-1 | Details |
| BOC-D-FMK | C11H18FNO5 | 634911-80-1 | Details |
| Bovinic acid | C18H32O2 | 2540-56-9 | Details |
| Retinyl palmitate | C36H60O2 | 79-81-2 | Details |
| BMY-25271 | C12H19N5O2S2 | 78441-82-4 | Details |
| BMT-124110 | C21H27N3O3 | 1679371-59-5 | Details |
| BMS-901715 | C22H28N10O | 1699861-37-4 | Details |
| BMVC | C28H25IN3+ | 627810-06-4 | Details |
| BMT-145027 | C23H14ClF3N4 | 2018282-44-3 | Details |
| Azilsartan | C25H20N4O5 | 147403-03-0 | Details |
| Fostemsavir Tris | C29H37N8O11P | 864953-39-9 | Details |
| BRCA1-IN-1 | C27H33F2N4O6P | 1622262-74-1 | Details |
| BR351 precursor | C27H32N2O8S2 | 960113-89-7 | Details |
| BRAF inhibitor | C22H18F2N4O3S | 918505-61-0 | Details |
| BPR1M97 | C18H18Cl2N2O | 2059904-66-2 | Details |
| bpV(phen) | C12H8KN2O5V | 42494-73-5 | Details |
| BQ-788 sodium salt | C34H52N5NaO7 | 156161-89-6 | Details |
| BR102375 | C31H34N6O4 | 2366255-59-4 | Details |
| BR351 | C20H25FN2O5S | 960113-85-3 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 | ||||